News

FDA Calls for Heartburn Drug Zantac to be Pulled from Market Immediately


After alerts that it issued last fall, the FDA decided on April 1, 2020, to ask all manufacturers of products containing ranitidine to remove their products from the market. An oral histamine-2 (H2) blocker, ranitidine was available both with and without a prescription. Sold under the brand-name, Zantac® (Chattem, a subsidiary of Sanofi), and numerous …

2020 Updates for Drug Reference Guides


Our “Workers’ Compensation Pharmaceuticals: Prior Authorization and High Dollar Rejections Guide” and our “Brand to Generic Reference Guide: Workers’ Compensation Pharmaceuticals” are two of the most widely used reference materials at myMatrixx. Due to the constantly changing nature of the pharmaceuticals industry, it’s important to keep these guides updated regularly. Our team has recently released …

myMatrixx Leaders to Present at Upcoming RIMS Chapter Events


In a recent update, we shared that myMatrixx Clinical Account Executive Shanea McKinney has had multiple speaking proposals accepted to RIMS, the risk management society’s Professional Exchange of Risk Knowledge, or PERK, program. Well, we’re pleased to announce that two separate RIMS chapters have already selected the presentation, “Medical Marijuana’s Impact on Workers’ Comp” for …